Furosemide
- Product NDC
- 31722-309
- 11-digit product format
- 317220309
- Labeler code
- 31722
- Product ID
- 31722-309_2ce6b13e-910d-7342-e063-6394a90a92ca
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Furosemide
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Camber Pharmaceuticals, Inc.
- Application
- ANDA217557
- Marketing category
- ANDA
- Marketing start
- 2024-12-13
- Substance
- FUROSEMIDE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Furosemide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FUROSEMIDE | 10 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7LXU5N7ZO5 |
| Rxcui | 1719286, 1719290, 1719291 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 31722-309-31 | Furosemide | 2 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 2 | | 1 |
| 31722-309-32 | Furosemide | 25 in 1 BOX | INJECTION, SOLUTION | 25 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 31722-309 | FUROSEMIDE (FUROSEMIDE) INJECTION, SOLUTION [CAMBER PHARMACEUTICALS, INC.] | 1 | Current NDC, 2 package rows | 20250131_f6221cce-e586-4002-bd14-6ec22eb14e2e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 31722-309-31 | 31722030931 | 2 mL in 1 VIAL, GLASS | 2 ml | | | | Historical |
| 31722-309-32 | 31722030932 | 25 VIAL, GLASS in 1 BOX (31722-309-32) / 2 mL in 1 VIAL, GLASS (31722-309-31) | | 2024-12-13 | No | No | Current |